Longboard Pharmaceuticals Probability of Future Stock Price Finishing Under 8.84
| LBPHDelisted Stock | USD 59.98 0.00 0.00% |
Longboard |
Longboard Pharmaceuticals Target Price Odds to finish below 8.84
The tendency of Longboard Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 8.84 or more in 90 days |
| 59.98 | 90 days | 8.84 | near 1 |
Based on a normal probability distribution, the odds of Longboard Pharmaceuticals to drop to $ 8.84 or more in 90 days from now is near 1 (This Longboard Pharmaceuticals probability density function shows the probability of Longboard Stock to fall within a particular range of prices over 90 days) . Probability of Longboard Pharmaceuticals price to stay between $ 8.84 and its current price of $59.98 at the end of the 90-day period is about 82.08 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.04 . This indicates Longboard Pharmaceuticals market returns are responsive to returns on the market. As the market goes up or down, Longboard Pharmaceuticals is expected to follow. Additionally Longboard Pharmaceuticals has an alpha of 0.9629, implying that it can generate a 0.96 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Longboard Pharmaceuticals Price Density |
| Price |
Predictive Modules for Longboard Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Longboard Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Longboard Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Longboard Pharmaceuticals is not an exception. The market had few large corrections towards the Longboard Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Longboard Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Longboard Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.96 | |
β | Beta against Dow Jones | 1.04 | |
σ | Overall volatility | 13.08 | |
Ir | Information ratio | 0.13 |
Longboard Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Longboard Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Longboard Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Longboard Pharmaceuticals is not yet fully synchronised with the market data | |
| Longboard Pharmaceuticals is way too risky over 90 days horizon | |
| Longboard Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Longboard Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (54.42 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Longboard Pharmaceuticals currently holds about 87.42 M in cash with (50.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.09. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Longboard Pharmaceuticals concludes merger with H. Lundbeck AS |
Longboard Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Longboard Stock often depends not only on the future outlook of the current and potential Longboard Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Longboard Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.7 M | |
| Cash And Short Term Investments | 48.5 M |
Longboard Pharmaceuticals Technical Analysis
Longboard Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Longboard Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Longboard Pharmaceuticals. In general, you should focus on analyzing Longboard Stock price patterns and their correlations with different microeconomic environments and drivers.
Longboard Pharmaceuticals Predictive Forecast Models
Longboard Pharmaceuticals' time-series forecasting models is one of many Longboard Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Longboard Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Longboard Pharmaceuticals
Checking the ongoing alerts about Longboard Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Longboard Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Longboard Pharmaceuticals is not yet fully synchronised with the market data | |
| Longboard Pharmaceuticals is way too risky over 90 days horizon | |
| Longboard Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Longboard Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (54.42 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Longboard Pharmaceuticals currently holds about 87.42 M in cash with (50.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.09. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Longboard Pharmaceuticals concludes merger with H. Lundbeck AS |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |